
- December 2012 Heart Health
- Volume 78
- Issue 12
Glycemic Responses To Rice Differ by Ethnicity
Although rice is a staple food of China, a recent study published online on November 26, 2012, by Diabetic Medicine suggests that the food increases the risk of type 2 diabetes more so in the Chinese population than in European populations.
The study compared the glycemic responses to glucose and 5 rice varieties in people of European and Chinese ethnicity and examined ethnic differences in postprandial hyperglycemia. Researchers measured glycemic responses of healthy Chinese and European volunteers on 8 occasions after eating glucose and either jasmine, basmati, brown, Doongara, or parboiled rice. Researchers also collected data on participants’ physical activity levels.
The glycemic responses of the Chinese participants to the 5 rice types were 60% greater than European participants. Responses to glucose were 39% higher among Chinese participants. Basmati rice had the lowest glycemic response, with the response to other varieties being approximately 20% greater.
The findings are especially important in light of the fact that China has high diabetes rates. The study suggests that recommendations regarding dietary carbohydrates should be reviewed for rice-eating populations at high risk for diabetes.
Articles in this issue
almost 13 years ago
Pharmacogenomics and the Most Commonly Prescribed Drugs of 2011almost 13 years ago
Improving Heart Health with Better Sleepalmost 13 years ago
Obstructive Sleep Apnea: An Important Wake-Up Callalmost 13 years ago
Can You Read These Rxs?almost 13 years ago
Case Studiesalmost 13 years ago
Systems Problems Among Roots of Tech-Related Medication Errorsalmost 13 years ago
Your Compounding Questions Answeredalmost 13 years ago
The Power of Words: A New Approach to Counselingalmost 13 years ago
Pharmacist Terminated in Violation of Public Policy?almost 13 years ago
New FDA Board to Handle Exclusivity DecisionsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.